198 hasil
Menampilkan 1–20 · 0,44 detik · RSS
Thalassemia Reports
ISSN 2039-4357 · MDPI AG · 198 artikel di indeks
-
Artikel Jurnal
Efficacy of ruxolitinib as inducer of fetal hemoglobin in primary erythroid cultures from sickle cell and beta-thalassemia patients
High levels of HbF may ameliorate the clinical course of β-thalassaemia and SCD. Hydroxyurea (HU) is the only HbF inducer approved for the treatment of patients. However not all patients respond to the treatment, for this reason it is noteworthy to identify new HbF inducers. Ruxolitinib is a JAK…
-
Artikel Jurnal
Migration: The aftershocks to the provision of healthcare
Migration is the “movement of people to a new area or country in order to find work or better living conditions” (Oxford dictionary). The term “migration” summarizes forced, reluctant and voluntary migration. Voluntary migration is a comparatively constant event. But reluctant and, in particular…
-
Artikel Jurnal
Safety and efficacy of drugs: What do I need to know?
Access to the essential medicines is an important challenge in the developing countries. To have access to the quality and affordable medicines, the pharmaceutical decision makers try different strategies. The production of generic and copy medicines is one of the strategies that if adopted based…
-
Artikel Jurnal
Diagnosis of haemoglobinopathies: New scientific advances
The molecular defects underlying haemoglobinopathies are both deletions and point mutations in the alpha- or beta-globin genes or gene-clusters. To detect point mutations causing alpha- or beta-thalassaemia, direct sequencing is the method of choice to detect the widest spectrum of molecular…
-
Artikel Jurnal
TIF conference presentation in detail
The factors determining the health behaviours may be seen in various contexts: physical, socio-economic, cultural and political. So the utilization of a health care system, public or private, formal or non-formal, may depend on socio-demographic factors, social structures, level of education…
-
Artikel Jurnal
The role of the clinical nurse specialist in haemoglobinopathies
The role of the Clinical Nurse Specialist (CNS) is an everdeveloping role that is integral in the care of individuals with haemoglobinopathies. Haemoglobinopathies are complex disorders that require specialist knowledge to deliver the very best care. In order to offer the best possible patient…
-
Artikel Jurnal
New challenges in diagnosis of haemoglobinopathies: Migration of populations
The current influx of economic migrants and asylum seekers from countries with a high prevalence of haemoglobinopathies creates new challenges for health care systems and diagnostic laboratories. The migration of carriers introduces new and novel haemoglobinopathy mutations to the diagnostic…
-
Artikel Jurnal
Informed choice in a multicultural world
Knowledge and autonomy are key aspects of informed choice; it is important to define what is important for participants to understand, when accepting or declining screening and for individuals to understand that screening is optional and their own personal choice There are no agreed thresholds or…
-
Artikel Jurnal
Renal complications in thalassemia
Thalassemia is a disease with an extensive morbidity profile affecting almost every organ system. Renal involvement, once considered rare, is an underestimated and poorly studied complication that has been on the rise ever since medical advances granted patients longer life spans. Several studies…
-
Artikel Jurnal
β globin mutations in Turkish, Northern Iraqi and Albanian patients with β thalassemia major
The mutation detection of β thalassemia is absolutely necessary for molecular diagnosis, as well as any genetic epidemiological study. The β globin gene has 3 exons and 2 introns, involved in β-thalassemic pathogenesis. The study aim of the study is to characterize the spectrum of β globin gene…
-
Artikel Jurnal
Let’s talk about thal: How communication can improve quality of life
In many parts of the world, research, improved technology, and better medicine have enabled people with thalassemia to live longer. It is tragic that due to global disparity in healthcare, in areas of the world where thalassemia is most prevalent, the mortality rates are high, and often, patients…
-
Artikel Jurnal
Hepatitis C virus treatment advances for thalassaemia patients
Chronic infection with hepatitis C virus (HCV) is a major problem for thalassaemia patients, as blood transfusions before 1990 were associated with a high risk of HCV infection. Given the high prevalence of co-morbidities, thalassaemia patients are at an increased risk for dying from end-stage…
-
Artikel Jurnal
Haemoglobinopathies care and cure: Have we reached the end?
Recent years have seen accelerating advances in the treatment, monitoring and potential cures for haemoglobin disorders, as the interaction between basic science, pharmaceutical research, and practical medicine intensifies. In order to appreciate how close to the end we may have reached, it is…
-
Artikel Jurnal
Iron overload and chelation therapy in hemoglobinopathies
Iron overload (IOL) is highly prevalent among patients with hemoglobinopathies; both transfusion dependent thalassemia (TDT) and non-transfusion dependent thalassemia (NTDT). Whether IOL is secondary to regular transfusions like in TDT, or develops from increased intestinal absorption like in NTDT…
-
Artikel Jurnal
Diagnostic strategies in hemoglobinopathy testing, the role of a reference laboratory in the USA
Although commonly assessed in the context of microcytosis or sickling syndrome screening, hemoglobin mutations may not be as readily considered as a cause of other symptoms. These include macrocytosis with or without anemia, chronic or episodic hemolysis, neonatal anemia, erythrocytosis…
-
Artikel Jurnal
Optimal blood transfusion therapy in haemoglobinopathies
For reasons of time, this short talk will be confined to the optimal frequency, timing, indications and dosing of blood transfusion. Blood transfusion protocols in thalassaemia syndromes are more widely agreed (1) than for sickle disorders but questions still remain about optimal Hb levels, timing…
-
Artikel Jurnal
Endocrine complications
More than five decades ago, thalassemia major (TM) was fatal in the first decade of life. This poor prognosis changed since the survival rates started to increase progressively thanks to the implementation of continuous and significant improvement of diagnostic and therapeutic methods, consisting…
-
Artikel Jurnal
Heart disease in patients with haemoglobinopathies
Hereditary hemoglobin disorders, also termed haemoglobinopathies, include mainly beta -thalasszemia and sickle cell disease and represent the most common monogenic disorders in human. Cardiac complications are still a leading cause of mortality and morbidity in patients with haemoglobinopathy…
-
Artikel Jurnal
Investigation of some endogenous antimicrobial peptides in thalassemia
The aim of this work was a comparative study of the amount of antimicrobial peptides - human neutrophil peptides - defensins (HNP), hepcidin, bactericidal/permeability-increasing protein (BPI), and endotoxin in β-thalassemia. Blood samples of 135 patients with thalassemia were investigated. All…
-
Artikel Jurnal
PIGI ZOIS: Pioneering with credibility
Annual transfusion requirements in Greece exceed 600000 blood units and nearly 20% of them are used for the transfusion of 3.000 patients with Thalassemia. Thalassemia patients need to be transfused properly at the right time and with safe, fresh blood. PIGI ZOIS is a nonprofit organization that…